VIPDOMET

This brand name is authorized in Austria, Croatia, Estonia, Finland, France, Ireland, Italy, Lithuania, Poland, Spain, UK.

Active ingredients

The drug VIPDOMET contains a combination of these active pharmaceutical ingredients (APIs):

1	Alogliptin UNII JHC049LO86 - ALOGLIPTIN
	Alogliptin is a potent and highly selective inhibitor of DPP-4, >10,000-fold more selective for DPP-4 than other related enzymes including DPP-8 and DPP-9. Alogliptin improves glycaemic control via a glucose-dependent mechanism, whereby insulin release is enhanced and glucagon levels are suppressed when glucose levels are high.
	Read more about Alogliptin
2	Metformin UNII 786Z46389E - METFORMIN HYDROCHLORIDE
	Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.
	Read more about Metformin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VIPDOMET Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BD13	Metformin and alogliptin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD13

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1627028, 1627039, 1627040, 1627051, 1627062, 1627073, 1627084, 1627095, 1627107, 1627118, 1627129, 1627130, 1627141, 1627152, 1627163, 1627174, 1627185, 1627196, 1627208, 1627219, 1627220, 1627231, 1627242, 1627253, 1836749, 1836750
ES	Centro de información online de medicamentos de la AEMPS	113843005, 113843008, 113843017, 113843020
FI	Lääkealan turvallisuus- ja kehittämiskeskus	470763
FR	Base de données publique des médicaments	66037572, 66741854
GB	Medicines & Healthcare Products Regulatory Agency	236328, 381747, 392398
IT	Agenzia del Farmaco	043045018, 043045020, 043045032, 043045044, 043045057, 043045069, 043045071, 043045083, 043045095, 043045107, 043045119, 043045121, 043045133, 043045145, 043045158, 043045160, 043045172, 043045184, 043045196, 043045208, 043045210, 043045222, 043045234, 043045246, 043045259, 043045261
LT	Valstybinė vaistų kontrolės tarnyba	1071444, 1071445, 1071446, 1071447, 1071448, 1071449, 1071450, 1071451, 1071452, 1071453, 1071454, 1071455, 1071456, 1071457, 1071458, 1071459, 1071460, 1071461, 1071462, 1071463, 1071464, 1071465, 1071466, 1071467, 1075882, 1075883
PL	Rejestru Produktów Leczniczych	100313894, 100313902